8 key findings from an AI-focused survey of C-suite execs

It’s long past asking “if” artificial intelligence (AI) and related technologies will revolutionize healthcare. According to a recent survey, 80 percent of executives expect AI will be integrated into the patient experience within two years. At the same time, 81 percent of respondents agree their organizations are not ready for the societal and liability issues that will result from this change.

Leading health organizations collaborate with industry on new initiative to combat growing diabetes and cardiovascular disease threat

DALLAS, June 15, 2018 – The American Heart Association (AHA) and the American Diabetes Association (ADA) today announced the start of a new multi-year collaborative initiative supported by founding sponsors Boehringer Ingelheim, Eli Lilly and Company (Lilly), and Novo Nordisk.

Avinger Announces First Patients Enrolled in Post-Market Study Comparing Pantheris OCT Imaging to Intravascular Ultrasound

REDWOOD CITY, Calif., June 14, 2018 — Avinger, Inc. (AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the initiation of the SCAN study, a post-market study comparing optical coherence tomography (OCT) with intravascular ultrasound (IVUS) as a diagnostic imaging tool in the peripheral arteries.